This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Infectious Salmon Anemia | |
|---|---|
| Name | Infectious Salmon Anemia |
| Field | Veterinary medicine, Aquaculture |
| Symptoms | Anemia, hemorrhaging, exophthalmia, ascites |
| Onset | Acute to subacute |
| Causes | Orthomyxoviridae family virus |
| Risks | Atlantic salmon aquaculture, poor biosecurity, wild farm interface |
| Diagnosis | Histopathology, PCR, virus isolation, ELISA |
| Prevention | Biosecurity, surveillance, vaccination, culling |
| Medication | Supportive care, fallowing, movement restrictions |
Infectious Salmon Anemia is a viral disease affecting farmed Atlantic salmon that causes severe anemia, high mortality, and significant impacts on aquaculture operations. First described in the late 20th century, the disease has prompted regulatory responses, coordinated surveillance, and research programs across multiple countries and institutions. Outbreaks have influenced trade, policy, and investment in regions with intensive salmon production.
The disease was first recognized during major outbreaks in the 1980s and 1990s that prompted attention from Norway, Canada, United Kingdom, Chile, and United States authorities, as well as international organizations such as the World Organisation for Animal Health and the Food and Agriculture Organization. Regulatory frameworks led by agencies like the Norwegian Veterinary Institute, Canadian Food Inspection Agency, Marine Scotland Science, and regional ministries shaped containment responses. Industry stakeholders including Marine Harvest (now Mowi ASA), SalMar, Cermaq, and national aquaculture associations adjusted husbandry, biosecurity, and market practices. Scientific collaborations among universities such as the University of Bergen, University of Prince Edward Island, University of Santiago de Compostela, and research centers including the Institute of Marine Research (Norway) advanced diagnostics and epidemiology.
The causative agent is an orthomyxovirus in the family Orthomyxoviridae that shares taxonomic context with viruses studied by institutions like the Centers for Disease Control and Prevention and the University of Cambridge virology groups. Molecular characterization by laboratories at the Norwegian Institute of Public Health and the National Research Council (Canada) has identified genome segments analogous to those described in viral genomics research at the Wellcome Sanger Institute and Broad Institute. Pathogenesis studies by teams at the Institute of Aquaculture (University of Stirling), Stellenbosch University, and the University of Glasgow demonstrated viral replication in erythrocytes and endothelial cells, causing anemia, hemorrhage, and organ dysfunction. Comparative virology frameworks used by the American Society for Microbiology and evolutionary analyses published by researchers associated with the Max Planck Society informed understanding of strain diversity and reassortment.
Primary susceptible hosts include farmed Salmo salar stock maintained by companies like Cooke Aquaculture and breeding programs at institutes such as the Atlantic Veterinary College. Wild salmonid species, migratory populations monitored by agencies like the North Atlantic Salmon Conservation Organization and conservation groups including WWF and IUCN have been assessed for spillover risk. Transmission pathways were elucidated through epidemiological studies involving the Fisheries and Oceans Canada research fleet and Norwegian fjord monitoring programs coordinated with ICES and regional laboratories. Vectors and fomites implicated in spread include contaminated equipment, live fish movements regulated under agreements like the Sanitary and Phytosanitary Measures frameworks, and possibly carrier species investigated by marine biologists at the Scripps Institution of Oceanography.
Clinically affected stock shows pale gills, ascites, hemorrhagic lesions, exophthalmia, and lethargy as documented in diagnostic manuals from OIE and case reports submitted to the European Food Safety Authority. Diagnostic approaches rely on histopathology protocols from veterinary pathology units at the Royal Veterinary College, molecular assays such as RT-PCR developed in laboratories at the National Veterinary Services Laboratories and ELISA platforms validated by centers like the Veterinary Laboratories Agency. Virus isolation in cell lines maintained by the American Type Culture Collection and sequencing at facilities including the Wellcome Trust Sanger Institute provide confirmatory data used by ministries like the Ministry of Fisheries and Oceans (Canada) and national reference labs.
Epidemiological patterns have been analyzed in studies led by research groups at Dalhousie University, University of British Columbia, and the University of Oslo, showing spatiotemporal links to oceanographic conditions studied by institutions such as NOAA and The Fisheries Research Agency (Japan). Economic assessments by consultants and economists linked to organizations like the World Bank, OECD, and national departments of trade quantified direct losses, trade disruptions, and employment effects in regions where companies such as Mowi ASA, Grieg Seafood, and Bakkafrost operate. Policy responses involving compensation schemes, traceability mandates, and export restrictions were implemented in coordination with bodies like the European Commission and national parliaments.
Control strategies emphasize biosecurity measures advocated by the Norwegian Food Safety Authority, coordinated surveillance under OIE guidelines, movement controls similar to protocols used in Avian influenza and Foot-and-mouth disease management, and industry standards promoted by trade groups including the Global Salmon Initiative. Operational measures include site fallowing, synchronized stocking, disinfection protocols developed with input from laboratories such as AquaBioTech Group, and contingency planning aligned with national emergency frameworks. Culling and stamping-out policies have been applied following detection events, with compensation mechanisms administered by state authorities like the Government of Chile and provincial governments in Canada.
Research programs at universities including the University of Stirling, University of Copenhagen, and institutes such as the Norwegian Veterinary Institute have advanced vaccine platforms, immunogenicity studies, and challenge trials. Commercial vaccine development by biotechnology firms in partnership with corporations like Zoetis and smaller biotech startups followed regulatory pathways overseen by agencies including the European Medicines Agency and Health Canada. Ongoing studies in molecular epidemiology, host immunity, and antiviral strategies are supported by grants from entities like the European Research Council, National Science Foundation, Natural Sciences and Engineering Research Council of Canada, and philanthropic funders such as the Gates Foundation where relevant to comparative virology. Collaborative networks involving ICES, FAO, OIE, and academic consortia continue to prioritize surveillance, strain characterization, and deployment of effective vaccines and management practices.
Category:Fish diseases Category:Aquaculture